Page 20 - Replimune Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities Research Analysts’ updated eps estimates for Tuesday, May 24th: Ares Commercial Real Estate (NYSE:ACRE) had its buy rating reiterated by analysts at JMP Securities. The firm currently has a $16.50 target price on the stock. Assura (LON:AGR) had its buy rating reissued by analysts at Shore Capital. Assura (LON:AGR) had its add rating reaffirmed […]

Analysts’ price target changes for Friday, May 20th: Autodesk (NASDAQ:ADSK) had its price target lowered by Citigroup Inc. from $286.00 to $264.00. They currently have a buy rating on the stock. Applied Materials (NASDAQ:AMAT) had its price target cut by Barclays PLC from $150.00 to $125.00. They currently have an equal weight rating on the […]

Replimune Group (NASDAQ:REPL – Get Rating) had its price target reduced by Piper Sandler from $52.00 to $44.00 in a report issued on Thursday, The Fly reports. Piper Sandler’s price objective would suggest a potential upside of 201.16% from the stock’s previous close. A number of other brokerages have also recently commented on REPL. BMO […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

In this piece, we will take a look at the top five best stocks to buy under $20 according to Jeremy Green's Redmile Group.